Hernandez Vargas, S.; Aghaamiri, S.; Adams, J.T.; Bateman, T.M.; Acidi, B.; Ghosh, S.C.; Khalaj, V.; Kaseb, A.O.; Tran Cao, H.S.; Momeny, M.;
et al. Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications. Curr. Oncol. 2025, 32, 512.
https://doi.org/10.3390/curroncol32090512
AMA Style
Hernandez Vargas S, Aghaamiri S, Adams JT, Bateman TM, Acidi B, Ghosh SC, Khalaj V, Kaseb AO, Tran Cao HS, Momeny M,
et al. Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications. Current Oncology. 2025; 32(9):512.
https://doi.org/10.3390/curroncol32090512
Chicago/Turabian Style
Hernandez Vargas, Servando, Solmaz Aghaamiri, Jack T. Adams, Tyler M. Bateman, Belkacem Acidi, Sukhen C. Ghosh, Vahid Khalaj, Ahmed O. Kaseb, Hop S. Tran Cao, Majid Momeny,
and et al. 2025. "Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications" Current Oncology 32, no. 9: 512.
https://doi.org/10.3390/curroncol32090512
APA Style
Hernandez Vargas, S., Aghaamiri, S., Adams, J. T., Bateman, T. M., Acidi, B., Ghosh, S. C., Khalaj, V., Kaseb, A. O., Tran Cao, H. S., Momeny, M., & Azhdarinia, A.
(2025). Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications. Current Oncology, 32(9), 512.
https://doi.org/10.3390/curroncol32090512